Pediatric Albuterol Dosing for Acute Bronchospasm and Prophylaxis
For acute bronchospasm in children ≥2 years old, use 0.15 mg/kg (minimum 2.5 mg) every 20 minutes for 3 doses, then 0.15-0.3 mg/kg (up to 10 mg) every 1-4 hours as needed; for prophylaxis, use 2.5 mg three to four times daily. 1, 2
Acute Bronchospasm Treatment
Initial Dosing (First Hour)
- Weight-based dosing: 0.15 mg/kg per dose
- Minimum dose: 2.5 mg (one full vial of 0.083% solution)
- Frequency: Every 20 minutes for 3 doses 1
- Children <15 kg: Use 0.5% solution instead of 0.083% if requiring less than a full vial 2
Subsequent Dosing (After First Hour)
- Range: 0.15-0.3 mg/kg per dose
- Maximum: 10 mg per dose
- Frequency: Every 1-4 hours as needed 1
Continuous Nebulization (Severe Cases)
- Dose: 0.5 mg/kg/hour 1
- Recent evidence: Starting at 10 mg/hour provides comparable outcomes to 15 mg/hour in critical asthma, with shorter treatment duration 3
Prophylaxis/Maintenance Dosing
Standard Prophylactic Dose
- Dose: 2.5 mg (one full vial)
- Frequency: Three to four times daily 2
- Patient criteria: Children ≥2 years old weighing ≥15 kg 2
This dosing is for ongoing bronchospasm control, not for exercise-induced bronchospasm prophylaxis, which requires different timing and potentially different agents.
Critical Implementation Points
Delivery Considerations
- Dilute aerosols to minimum 3 mL at gas flow of 6-8 L/min 1
- Delivery time should be 5-15 minutes 2
- For children <4 years: Use valved holding chamber (VHC) with face mask if using MDI 1
Response Assessment
- Reassess after 60-90 minutes (after 3 initial doses) 1
- Response to initial treatment is a better predictor of hospitalization need than initial severity 1
- Patients requiring admission typically show diminished response from the first dose 4
When Higher Doses May Be Needed
The evidence shows that two-thirds of patients respond adequately to standard dosing (5-7.5 mg total in first hour), but one-third are relatively resistant 5. These non-responders are characterized by:
- More severe obstruction at presentation (PEFR <40% predicted after initial treatment)
- History of recurrent hospitalizations and ED visits 5
However, routine use of higher doses (>2.5 mg per treatment) shows no advantage in most patients 4. The 1990 study by Schuh et al. 6 showed benefit from 0.30 mg/kg hourly dosing versus 0.15 mg/kg, but this conflicts with more recent evidence showing no benefit from routine high-dose therapy 4.
Common Pitfalls to Avoid
Don't use frequent low doses (0.075 mg/kg every 30 minutes) instead of standard dosing—this provides no additional benefit and increases vomiting 7
Don't delay reassessment—failure to improve after the first hour of treatment indicates need for hospitalization and additional therapies 1
Don't continue escalating albuterol indefinitely in non-responders—these patients need systemic corticosteroids and potentially other interventions (ipratropium, magnesium, etc.) 1
Don't use albuterol alone for prophylaxis in persistent asthma—patients ≥12 years with mild persistent asthma should receive ICS-based therapy 8
Age-Specific Considerations
- Ages 2-11 years: Use weight-based dosing as above; MDI with VHC is as effective as nebulizer with proper technique 1
- Ages ≥12 years: Can use adult dosing (2.5-5 mg every 20 minutes × 3, then 2.5-10 mg every 1-4 hours) 1
The FDA label specifically indicates use for children ≥2 years old 2, and the NAEPP guidelines provide dosing for children ≥12 years as a distinct category 1.